Is higher dose always the right answer in stereotactic body radiation therapy for small hepatocellular carcinoma?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is higher dose always the right answer in stereotactic body radiation therapy for small hepatocellular carcinoma?

Published:2018-06-30 Issue:2 Volume:36 Page:129-138
ISSN:2234-1900
Container-title:Radiation Oncology Journal
language:en
Short-container-title:Radiat Oncol J

Author:

Lee Kyung Hwa,Yu Jeong Il,Park Hee Chul,Park Su Yeon,Shin Jung Suk,Shin Eun Hyuk,Cho Sungkoo,Jung Sang Hoon,Han Young Yih,Lim Do Hoon

Publisher

Korean Society for Therapeutic Radiology and Oncology

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

http://e-roj.org/upload/pdf/roj-2017-00598.pdf

Reference24 articles.

1. Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis

2. Management of hepatocellular carcinoma

3. Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Meta-Analysis of Randomized Controlled Trials

4. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

5. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal hypofractionated radiation therapy schemes for early-stage hepatocellular carcinoma;Radiotherapy and Oncology;2024-05

2. Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors;Liver Cancer;2023

3. Hypofractionation in Hepatocellular Carcinoma – The Effect of Fractionation Size;Clinical Oncology;2022-05

4. Favorable response to multimodal treatment in hepatocellular carcinoma with inferior vena cava and right atrial tumor thrombus and left adrenal gland metastasis;Medicine;2021-12-10

5. Stereotactic body radiation therapy for small (≤5 cm) hepatocellular carcinoma not amenable to curative treatment: Results of a single-arm, phase II clinical trial;Clinical and Molecular Hepatology;2020-10-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3